Results 71 to 80 of about 1,295 (151)

Preparation, characterization and in vitro antiviral activity evaluation of foscarnet-chitosan nanoparticles [PDF]

open access: yes, 2014
A new nanoparticulate system for foscarnet delivery was prepared and evaluated. Nanoparticles were obtained by ionotropic gelation of chitosan induced by foscarnet itself, acting as an ionotropic agent in a manner similar to tripolyphosphate anion.
Donalisio, Manuela   +12 more
core   +1 more source

Preparation and characterization of foscarnet/chitosan nanoparticles

open access: yes, 2010
Purpose: Foscarnet is an antiviral agent which inhibits the activity of herpesvirus DNA polymerase, including herpes simplex virus types 1 and 2, varicella zoster, cytomegalovirus, human immunodeficiency virus (HIV) and other viruses.
PARODI, BRUNELLA   +3 more
core   +1 more source

Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir

open access: yes, 2018
Purpose: To report use of intravenous foscarnet or cidofovir for the treatment of refractory acute retinal necrosis (ARN). Methods: Retrospective chart review. Results: Four immunocompetent men aged 45-90 years presented with ARN from 2008-2014.
Durand, Marlene L.   +8 more
core   +1 more source

Foscarnet effects on the rat pregnancy outcome

open access: yes, 2017
Foscarnet es un inhibidor de la transcriptasis reversa del HIV que actúa en la síntesis del DNA. En este trabajo evaluamos los efectos crónicos del foscarnet durante la preñez de la rata albina. Ratas preñadas fueron distribuidas aleatoriamente en cuatro
Venneri Mathias, Camila Fernandes   +6 more
core  

Herpes zoster verrucoso em doentes com SIDA.

open access: yesActa Médica Portuguesa, 1997
The authors describe a case of disseminated Herpes-Zoster (VZV) in an HIV 1 positive patient with AIDS. Hyperkeratotic characteristics, acyclovir resistance and sensitivity to foscarnet of cutaneous lesions are the most important features of this example.
V Agusto   +8 more
doaj   +1 more source

Leflunomide in the Treatment of a Pseudotumoral Genital Herpes Simplex Virus Infection in an HIV Patient

open access: yesCase Reports in Infectious Diseases, 2017
The patient is a 52-year-old African American man with a past medical history of HIV infection (on antiretroviral therapy, CD4 count 399 cells/µL, and undetectable HIV viral load) and recurrent genital herpes. While on valacyclovir, the patient presented
Marie R. Roger, Gregory M. Anstead
doaj   +1 more source

In vitro activity of six antiviral drugs against equid alphaherpesvirus type 1 indicates ganciclovir as promising drug for in vivo studies

open access: yesCiência Rural, 2018
: Equid alphaherpesvirus type 1 (EHV-1) is distributed worldwide and is a major agent of abortion, respiratory and neurological disease in horses. No specific treatment is available for EHV-1 infection, yet the potential of antiviral therapy has been ...
Amanda Lovato de Oliveira   +4 more
doaj   +1 more source

Human herpesvirus-6 (HHV-6) pneumonitis around the engraftment of cord blood transplantation (CBT) following foscarnet prophylaxis in a patient with acute leukemia

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2014
Humanherpesvirus-6 (HHV-6) reactivation is sometimes observed in immunocompromisedpatients, especially after allogeneic stem cell transplantation. Thecomplications of HHV-6 reactivation in this setting are mainly recognized asHHV-6 encephalitis.
Takashi Ishio
doaj  

Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient

open access: yesCase Reports in Transplantation, 2016
Cytomegalovirus (CMV) infection after lung transplantation is associated with increased risk for pneumonitis and bronchiolitis obliterans as well as allograft rejection and opportunistic infections.
Heinrike Wilkens, Martina Sester
doaj   +1 more source

Mononeuritis multiplex: an uncommon neurological manifestation of cytomegalovirus reactivation in an HIV-infected patient

open access: yesBMC Infectious Diseases, 2018
Background Cytomegalovirus (CMV) reactivation with neurological involvement in patients with acquired immunodeficiency syndrome (AIDS) is increasingly rare since the introduction of antiretroviral therapy (ART).
Pedro Palma   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy